Artwork

Content provided by Pharmacy Advisory Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharmacy Advisory Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Regulatory Considerations in Compounding Pharmacy Practice with Martha Rumore

34:01
 
Share
 

Manage episode 436376949 series 1523443
Content provided by Pharmacy Advisory Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharmacy Advisory Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, Our guest, Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA is a pharmacist-attorney in Frier Levitt’s Life Sciences Department. Her practice focuses on healthcare law; Food, Drug Cosmetic law; pharmacy law and regulatory issues; PBM issues; as well as pharmaceutical and medical device intellectual property including trademark, copyright, trade secret and all aspects of patent law (due diligence, prosecution, opinion work, litigation, and transactional matters). Dr. Rumore has over 15 years of law firm experience in the area of Food, Drug & Cosmetic Law and pharmaceutical intellectual property, counseling on early market opportunities for pharmaceutical clients particularly in the area of ANDA and 510K applications and all facets of Paragraph IV litigation.

Dr. Rumore has also worked in Drug Regulatory Affairs in the pharmaceutical industry and hospital pharmacy, both at the Director level. She taught Pharmacy Law and Drug Regulatory Affairs at Arnold & Marie Schwartz College of Pharmacy and Touro College of Pharmacy for close to 20 years and currently teaches Food, Drug & Cosmetic Law at Maurice A. Deane School of Law at Hofstra University.

She is a frequent lecturer and has over 200 publications and presentations. Additionally, Dr. Rumore is a Fellow and former Trustee of the American Pharmacists Association, a former Board member of the American Society for Pharmacy Law and the Accreditation Council for Pharmacy Education and is a three-time recipient of the Larry Simonsmeier Legal Writing Award.

This in-depth discussion on the current regulatory landscape for compounding pharmacies will look at:

  • Current Regulatory Environment for 503A and 503B Compounding
  • State Laws and State Board of Pharmacy 2023/2024
  • Important Regulatory Considerations in the 503B to 503A Compounding Model for Community Pharmacies
  • 506e Shortages and Beyond
  • USP 797/795 Six Months Later

Guest - Martha Rumore Senior Counsel

mrumore@frierlevitt.com

646.970.3226

Host - Hillary Blackburn, PharmD, MBA

www.hillaryblackburn.com

@HillBlackburn Twitter

★ Support this podcast on Patreon ★
  continue reading

260 episodes

Artwork
iconShare
 
Manage episode 436376949 series 1523443
Content provided by Pharmacy Advisory Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharmacy Advisory Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, Our guest, Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA is a pharmacist-attorney in Frier Levitt’s Life Sciences Department. Her practice focuses on healthcare law; Food, Drug Cosmetic law; pharmacy law and regulatory issues; PBM issues; as well as pharmaceutical and medical device intellectual property including trademark, copyright, trade secret and all aspects of patent law (due diligence, prosecution, opinion work, litigation, and transactional matters). Dr. Rumore has over 15 years of law firm experience in the area of Food, Drug & Cosmetic Law and pharmaceutical intellectual property, counseling on early market opportunities for pharmaceutical clients particularly in the area of ANDA and 510K applications and all facets of Paragraph IV litigation.

Dr. Rumore has also worked in Drug Regulatory Affairs in the pharmaceutical industry and hospital pharmacy, both at the Director level. She taught Pharmacy Law and Drug Regulatory Affairs at Arnold & Marie Schwartz College of Pharmacy and Touro College of Pharmacy for close to 20 years and currently teaches Food, Drug & Cosmetic Law at Maurice A. Deane School of Law at Hofstra University.

She is a frequent lecturer and has over 200 publications and presentations. Additionally, Dr. Rumore is a Fellow and former Trustee of the American Pharmacists Association, a former Board member of the American Society for Pharmacy Law and the Accreditation Council for Pharmacy Education and is a three-time recipient of the Larry Simonsmeier Legal Writing Award.

This in-depth discussion on the current regulatory landscape for compounding pharmacies will look at:

  • Current Regulatory Environment for 503A and 503B Compounding
  • State Laws and State Board of Pharmacy 2023/2024
  • Important Regulatory Considerations in the 503B to 503A Compounding Model for Community Pharmacies
  • 506e Shortages and Beyond
  • USP 797/795 Six Months Later

Guest - Martha Rumore Senior Counsel

mrumore@frierlevitt.com

646.970.3226

Host - Hillary Blackburn, PharmD, MBA

www.hillaryblackburn.com

@HillBlackburn Twitter

★ Support this podcast on Patreon ★
  continue reading

260 episodes

Alle Folgen

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide